View printer-friendly version |
<< Back |
Fourth Quarter and Fiscal Year 2024 Highlights
-
Quarterly net sales of
$640.8 million -
Quarterly net income of
$113.2 million , or$2.32 per diluted share -
Fiscal year net sales of
$2.3 billion and net income of$277.9 million , or$5.69 per diluted share -
Cash dividend of
$37.8 million , or$0.77 per share, pursuant to the Company’s established dividend policy
Overview
“Throughout the year, we continued to execute our growth strategy and deliver a favorable product mix in line with customer demand. Our operations ran well as we remained focused on our objective of operational excellence. We also completed two asset acquisitions in fiscal 2024 and completed one subsequent to the end of the fiscal year, each of which complements our organic growth initiatives. We are excited about the additions of the assets of
Sales Performance & Operating Highlights
“Net sales for fiscal 2024 were
“For the fourth fiscal quarter, we sold 285.6 million dozens shell eggs compared with 296.6 million dozens for the fourth quarter of fiscal 2023. Sales of conventional eggs totaled 180.5 million dozens, compared with 194.0 million dozens for the prior-year period, a decline of 7.0%, reflecting 13 weeks in the fourth quarter of fiscal 2024 compared to 14 weeks in the prior-year period. However, specialty egg volumes were 2.5% higher with 105.0 million dozens sold for the fourth quarter of fiscal 2024 compared with 102.5 million dozens sold for the fourth quarter of fiscal 2023.
“Net income attributable to
“Overall, our fourth quarter farm production costs per dozen were 14.3% lower compared to the prior-year period, primarily due to more favorable commodity pricing for key feed ingredients. For fiscal 2024, farm production costs per dozen were down 8.3%, primarily tied to lower feed costs. For the fourth quarter of fiscal 2024, feed costs per dozen were down 24.9% compared with the fourth quarter of fiscal 2023, and feed costs per dozen for fiscal 2024 were 18.6% lower compared with fiscal 2023.
“Current indications for corn supply project an overall better stocks-to-use ratio, implying more favorable prices in the near term. However, as we continue to face uncertain external forces including weather patterns and global supply chain disruptions, price volatility could remain,” said Bowman.
|
13 Weeks Ended
|
|
14 Weeks Ended
|
|
52 Weeks Ended
|
|
53 Weeks Ended
|
||||||||
Dozen Eggs Sold (000) |
|
285,555 |
|
|
|
296,554 |
|
|
|
1,147,633 |
|
|
|
1,147,373 |
|
Conventional Dozen Eggs Sold (000) |
|
180,513 |
|
|
|
194,031 |
|
|
|
746,687 |
|
|
|
749,076 |
|
Specialty Dozen Eggs Sold (000) |
|
105,042 |
|
|
|
102,523 |
|
|
|
400,946 |
|
|
|
398,297 |
|
Dozen Eggs Produced (000) |
|
243,851 |
|
|
|
276,354 |
|
|
|
1,018,835 |
|
|
|
1,058,540 |
|
% Specialty Sales (dozen) |
|
36.8 |
% |
|
|
34.6 |
% |
|
|
34.9 |
% |
|
|
34.7 |
% |
% Specialty Sales (dollars) |
|
38.5 |
% |
|
|
39.1 |
% |
|
|
41.4 |
% |
|
|
31.6 |
% |
Net Average Selling Price (per dozen) |
$ |
2.133 |
|
|
$ |
2.197 |
|
|
$ |
1.932 |
|
|
$ |
2.622 |
|
Net Average Selling Price of Conventional Eggs (per dozen) |
$ |
2.062 |
|
|
$ |
2.038 |
|
|
$ |
1.730 |
|
|
$ |
2.739 |
|
Net Average Selling Price of Specialty Eggs (per dozen) |
$ |
2.254 |
|
|
$ |
2.499 |
|
|
$ |
2.309 |
|
|
$ |
2.403 |
|
Feed Cost (per dozen) |
$ |
0.504 |
|
|
$ |
0.671 |
|
|
$ |
0.550 |
|
|
$ |
0.676 |
|
HPAI & Table Egg Supply Outlook
Outbreaks of HPAI have continued to occur in
During the third and fourth quarters of fiscal 2024,
The Company remains dedicated to robust biosecurity programs across its locations; however, no farm is immune from HPAI. HPAI is currently widespread in the wild bird population worldwide. The extent of possible future outbreaks, with heightened risk during the migration seasons, and more recent HPAI events, which have been directly linked to dairy cattle operations, cannot be predicted. According to the
Looking Ahead
Miller added, “We are proud of our performance in fiscal 2024, as we continued to execute our growth strategy in a challenging environment as well as respond to new market opportunities.
“Looking ahead to fiscal 2025, we believe demand for shell eggs will remain strong as consumers continue to look for more affordable protein options. As the largest producer and distributor of fresh shell eggs, we play an important role in meeting this demand and supporting the nation’s food supply with a differentiated product mix. We will continue to focus on expanding our production capacity for additional specialty and cage-free eggs that meet current consumer demand trends. Importantly, we have the financial strength to fund our internal expansion projects and to consider acquisitions that complement our operations and support our growth initiatives. Above all, we are committed to our mission to be the most reliable and sustainable producer of fresh shell eggs and egg products. We look forward to the opportunities ahead for
Dividend Payment
For the fourth quarter of fiscal 2024,
About
Forward Looking Statements
Statements contained in this press release that are not historical facts are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. The forward-looking statements are based on management’s current intent, belief, expectations, estimates and projections regarding our company and our industry. These statements are not guarantees of future performance and involve risks, uncertainties, assumptions and other factors that are difficult to predict and may be beyond our control. The factors that could cause actual results to differ materially from those projected in the forward-looking statements include, among others, (i) the risk factors set forth in the Company’s
FINANCIAL HIGHLIGHTS (Unaudited) (In thousands, except per share amounts)
SUMMARY STATEMENTS OF INCOME
|
||||||||||||
|
|
13 Weeks Ended
|
|
14 Weeks Ended
|
|
52 Weeks Ended
|
|
53 Weeks Ended
|
||||
Net sales |
|
$ |
640,789 |
|
$ |
688,680 |
|
$ |
2,326,443 |
|
$ |
3,146,217 |
Cost of sales |
|
|
454,353 |
|
|
490,588 |
|
|
1,784,872 |
|
|
1,949,760 |
Gross profit |
|
|
186,436 |
|
|
198,092 |
|
|
541,571 |
|
|
1,196,457 |
Selling, general and administrative |
|
|
57,781 |
|
|
62,159 |
|
|
252,625 |
|
|
232,207 |
Insurance recoveries |
|
|
(13,603) |
|
|
(125) |
|
|
(23,532) |
|
|
(3,345) |
(Gain) loss on disposal of fixed assets |
|
|
70 |
|
|
(167) |
|
|
26 |
|
|
(131) |
Operating income |
|
|
142,188 |
|
|
136,225 |
|
|
312,452 |
|
|
967,726 |
Other income, net |
|
|
9,773 |
|
|
9,690 |
|
|
47,519 |
|
|
30,824 |
Income before income taxes |
|
|
151,961 |
|
|
145,915 |
|
|
359,971 |
|
|
998,550 |
Income tax expense |
|
|
39,031 |
|
|
35,380 |
|
|
83,689 |
|
|
241,818 |
Net income |
|
|
112,930 |
|
|
110,535 |
|
|
276,282 |
|
|
756,732 |
Less: Loss attributable to noncontrolling interest |
|
|
(311) |
|
|
(396) |
|
|
(1,606) |
|
|
(1,292) |
Net income attributable to |
|
$ |
113,241 |
|
$ |
110,931 |
|
$ |
277,888 |
|
$ |
758,024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
2.32 |
|
$ |
2.28 |
|
$ |
5.70 |
|
$ |
15.58 |
Diluted |
|
$ |
2.32 |
|
$ |
2.27 |
|
$ |
5.69 |
|
$ |
15.52 |
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
48,761 |
|
|
48,689 |
|
|
48,717 |
|
|
48,648 |
Diluted |
|
|
48,902 |
|
|
48,838 |
|
|
48,873 |
|
|
48,834 |
|
|
|
|
|
|
|
|
|
|
|
|
|
FINANCIAL HIGHLIGHTS (Unaudited) (In thousands)
SUMMARY BALANCE SHEETS
|
||||||
|
|
|
|
|
||
ASSETS |
|
|
|
|
|
|
Cash and short-term investments |
|
$ |
812,377 |
|
$ |
647,914 |
Receivables, net |
|
|
162,442 |
|
|
187,213 |
Inventories, net |
|
|
261,782 |
|
|
284,418 |
Prepaid expenses and other current assets |
|
|
5,238 |
|
|
5,380 |
Current assets |
|
|
1,241,839 |
|
|
1,124,925 |
|
|
|
|
|
|
|
Property, plant and equipment, net |
|
|
857,234 |
|
|
744,540 |
Other noncurrent assets |
|
|
85,688 |
|
|
85,060 |
Total assets |
|
$ |
2,184,761 |
|
$ |
1,954,525 |
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|
|
|
Accounts payable and accrued expenses |
|
$ |
189,983 |
|
$ |
145,601 |
Dividends payable |
|
|
37,760 |
|
|
37,130 |
Current liabilities |
|
|
227,743 |
|
|
182,731 |
|
|
|
|
|
|
|
Deferred income taxes and other liabilities |
|
|
159,975 |
|
|
162,211 |
Stockholders' equity |
|
|
1,797,043 |
|
|
1,609,583 |
Total liabilities and stockholders' equity |
|
$ |
2,184,761 |
|
$ |
1,954,525 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20240723615663/en/
(601) 948-6813
Source: